Interaction between MUC1 and STAT1 drives IFITM1 overexpression in aromatase inhibitor-resistant breast cancer cells

被引：1
|
作者：
Lui, Asona
Lewis-Wambi, Joan
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2918
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2918
引用
收藏
页数：4
相关论文
共 50 条
  • [41] The Prognostic Value of STAT1 Overexpression and Clinicopathologic Features in Breast Cancer Patients Receiving Adjuvant Radiotherapy
    Chen, W-C
    Wu, C-L
    Lai, Y-H
    Chen, H-Y
    Chen, H. H. W.
    LABORATORY INVESTIGATION, 2013, 93 : 33A - 33A
  • [42] A microsatellite within the MUC1 locus at 1q21 is altered in the neoplastic cells of breast cancer patients
    Waltz, MR
    Pandelidis, SM
    Pratt, W
    Barnes, D
    Swallow, DM
    Gendler, SJ
    Cohen, EP
    CANCER GENETICS AND CYTOGENETICS, 1998, 100 (01) : 63 - 67
  • [43] The Prognostic Value of STAT1 Overexpression and Clinicopathologic Features in Breast Cancer Patients Receiving Adjuvant Radiotherapy
    Chen, W-C
    Wu, C-L
    Lai, Y-H
    Chen, H-Y
    Chen, H. H. W.
    MODERN PATHOLOGY, 2013, 26 : 33A - 33A
  • [44] Blockade of MUC1 Expression by Glycerol Guaiacolate Inhibits Proliferation of Human Breast Cancer Cells
    Smith, J. S.
    Colon, J.
    Madero-Visbal, R.
    Isley, B.
    Konduri, S. D.
    Baker, C. H.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2010, 10 (08) : 644 - 650
  • [45] MUC1 expression in human breast cancer cells is altered by the factors affecting cell proliferation
    Porowska, H
    Paszkiewicz-Gadek, A
    Wolczynski, S
    Gindzienski, A
    NEOPLASMA, 2002, 49 (02) : 104 - 109
  • [46] Vaccination with mucin gene (MUC1) transfected dendritic cells in patients with breast or pancreatic cancer
    Pecher, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S26 - S26
  • [47] Vaccination with Mucin gene (MUC1) transfected dendritic cells in patients with breast or pancreatic cancer
    Pecher, G
    Häring, A
    Schirrmann, T
    Krackhardt, A
    Thiel, E
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 68 - 68
  • [48] Localization of IFN-γ-activated Stat1 and IFN regulatory factors 1 and 2 in breast cancer cells
    Connett, JM
    Hunt, SR
    Hickerson, SM
    Wu, SJ
    Doherty, GM
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2003, 23 (11): : 621 - 630
  • [49] Phase II trial of the dual IGF-1R/IR inhibitor BMS-754807 with or without letrozole in aromatase inhibitor-resistant breast cancer.
    Haluska, P.
    Dhar, A.
    Hou, X.
    Huang, F.
    Nuyten, D. S. A.
    Park, J.
    Brodie, A. H.
    Ingle, J. N.
    Carboni, J. M.
    Gottardis, M. M.
    Wolff, A. C.
    Finckenstein, F. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] Phase I study of adoptive immunotherapy for advanced MUC1*positive breast cancer with autologous T cells engineered to express a chimeric antigen receptor, huMNC2-CAR44 specific for a cleaved form of MUC1 (MUC1*).
    Specht, Jennifer M.
    Maloney, David G.
    Yeung, Cecilia
    Wu, Vicky
    Bamdad, Cynthia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345